Trial · NCT03118739
Results by group168
Each measurement the trial posted, group by group, in the words and numbers it posted.
41 to 60 of 168
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Urinalysis | Verinurad 9 mg+Febuxostat 80 mg | Baseline Protein, mg/dL | 72.01 | Standard Deviation 99.767 | mg/dL |
| Urinalysis | Placebo | Baseline Protein, mg/dL | 65.74 | Standard Deviation 78.686 | mg/dL |
| Urinalysis | Verinurad 9 mg+Febuxostat 80 mg | Protein, mg/dL 12 weeks (CFB) | -11.40 | Standard Deviation 65.896 | mg/dL |
| Urinalysis | Placebo | Protein, mg/dL 12 weeks (CFB) | -4.07 | Standard Deviation 71.047 | mg/dL |
| Urinalysis | Verinurad 9 mg+Febuxostat 80 mg | Protein, mg/dL 24 weeks (CFB) | -16.73 | Standard Deviation 101.052 | mg/dL |
| Urinalysis | Placebo | Protein, mg/dL 24 weeks (CFB) | 11.40 | Standard Deviation 76.645 | mg/dL |
| Urinalysis | Verinurad 9 mg+Febuxostat 80 mg | Baseline Urine Albumin, mg/dL | 38.0907 | Standard Deviation 55.62178 | mg/dL |
| Urinalysis | Placebo | Baseline Urine Albumin, mg/dL | 35.8905 | Standard Deviation 47.17446 | mg/dL |
| Urinalysis | Verinurad 9 mg+Febuxostat 80 mg | Urine Albumin, mg/dL 12 weeks (CFB) | -9.4766 | Standard Deviation 35.73442 | mg/dL |
| Urinalysis | Placebo | Urine Albumin, mg/dL 12 weeks (CFB) | -0.3019 | Standard Deviation 45.81688 | mg/dL |
| Urinalysis | Verinurad 9 mg+Febuxostat 80 mg | Urine Albumin, mg/dL 24 weeks (CFB) | -6.9482 | Standard Deviation 50.66844 | mg/dL |
| Urinalysis | Placebo | Urine Albumin, mg/dL 24 weeks (CFB) | 11.6049 | Standard Deviation 53.13042 | mg/dL |
| Urinalysis | Verinurad 9 mg+Febuxostat 80 mg | Baseline Urine Creatinine, mg/dL | 96.52 | Standard Deviation 51.570 | mg/dL |
| Urinalysis | Placebo | Baseline Urine Creatinine, mg/dL | 86.25 | Standard Deviation 46.189 | mg/dL |
| Urinalysis | Verinurad 9 mg+Febuxostat 80 mg | Urine Creatinine, mg/dL 12 weeks (CFB) | 5.06 | Standard Deviation 53.378 | mg/dL |
| Urinalysis | Placebo | Urine Creatinine, mg/dL 12 weeks (CFB) | 12.95 | Standard Deviation 34.987 | mg/dL |
| Urinalysis | Verinurad 9 mg+Febuxostat 80 mg | Urine Creatinine, mg/dL 24 weeks (CFB) | 7.58 | Standard Deviation 55.930 | mg/dL |
| Urinalysis | Placebo | Urine Creatinine, mg/dL 24 weeks (CFB) | 8.53 | Standard Deviation 36.430 | mg/dL |
| Urinalysis | Verinurad 9 mg+Febuxostat 80 mg | Baseline Urine Urate, mg/dL | 28.354 | Standard Deviation 12.0591 | mg/dL |
| Urinalysis | Placebo | Baseline Urine Urate, mg/dL | 23.960 | Standard Deviation 10.6862 | mg/dL |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03118739/results?page=3